HTLV-II and Bacterial Infections Among Injection Drug Users
- 1 August 2000
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 24 (5) , 483-487
- https://doi.org/10.1097/00042560-200008150-00014
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The Clinical Epidemiology of Human T-Lymphotropic Virus Type II (HTLV-II)JAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Prototypical HTLV-I/II infection is rare in LGL leukemiaLeukemia Research, 1994
- Spastic ataxia associated with human T‐cell lymphotrophic virus type II infectionAnnals of Neurology, 1993
- Isolation of HTLV‐II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV‐I‐associated myelopathy/tropical spastic paraparesisAnnals of Neurology, 1993
- Progressive spastic myelopathy in a patient co-infected with HIV-1 and HTLV-IIAIDS, 1992
- Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemiaBlood, 1992
- Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infectionThe American Journal of Medicine, 1991
- Incidence of Hairy Cell Leukemia, Mycosis Fungoides, and Chronic Lymphocytic Leukemia in First Known HTLV-II-Endemic PopulationThe Journal of Infectious Diseases, 1991
- A clinical, hematologic, and immunologic analysis of 21 HTLV-II- infected intravenous drug users [published erratum appears in Blood 1990 Nov 1;76(9):1901]Blood, 1990
- A New Subtype of Human T-Cell Leukemia Virus (HTLV-II) Associated with a T-Cell Variant of Hairy Cell LeukemiaScience, 1982